Company: COOT
Filing Date: 2025-05-30
Form Type: 10-Q
Source: 0001641172-25-013065
Chunk: 18

Company: Australian Oilseeds Holdings Ltd
Filing Date: 2025-05-30
Form: 10-Q
Item: Item 8
Chunk 18
---
  
    Convertible Note 
     1,651,041  
     1,181,953 

9.
Issued Capital

There
have been no movements or changes in issued capital since 30 June 2024.

10.
Warrants

The
Company accounts for the Public warrants, the Private Placement warrants, the Representative warrants, the Penny warrants, and the Arena
Ordinary share warrants in accordance with the guidance contained in IAS 32 and IFRS 9 under which the Public warrants meet the criteria
for equity treatment and are recorded as equity due to the settlement provision in the warrant agreement. In accordance with IAS 32 and
IFRS 9, the Private Placement warrants, Representative warrants, the Penny warrants and Arena Ordinary share warrants (collectively the
“Warrants”) are initially required to be classified as liability instruments in its entirety; therefore, the Warrants are
required to be measured at fair value at each reporting period with changes in fair value recorded within earnings.

The
following table presents the warrants outstanding and exercisable on 31 March 2025 and 30 June 2024:

 Schedule of Warrant Outstanding

    Public warrants 
     9,000,000 
  
    Private Placement warrants 
     479,000 
  
    Representative warrants 
     450,000 
  
    Arena Ordinary share warrants 
     458,720 
  
    Total warrants 
     10,387,720 

Public,
Private, and Representative Warrants

As
part of EDOC’s IPO, EDOC issued warrants to third-party investors where each whole warrant entitles the holder to purchase one
share of the Company’s ordinary shares at an exercise price of USD$11.50 per share (the “Public Warrants”). Simultaneously
with the closing of the IPO, EDOC completed the private sale of warrants where each warrant allows the holder to purchase one share of
the Company’s ordinary shares at USD$11.50 per share. Additionally, the Company issued to the underwriters a warrant (“Representative’s
Warrant) to purchase up to 450,000 Class A ordinary shares stock at an exercise price of USD$11.50 per share.

These
warrants expire on the fifth anniversary of the Business Combination or earlier upon redemption or liquidation and are exercisable commencing
30 days after the Business Combination, provided that the Company has an effective registration statement under the Securities Act covering
the ordinary shares issuable upon exercise